Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Exponent Q3 2024 GAAP EPS $0.50 Beats $0.47 Estimate, Sales $136.279M Beat $125.670M Estimate

Author: Benzinga Newsdesk | October 24, 2024 03:09pm
Exponent (NASDAQ:EXPO) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.47 by 6.38 percent. The company reported quarterly sales of $136.279 million which beat the analyst consensus estimate of $125.670 million by 8.44 percent. This is a 2.21 percent increase over sales of $133.336 million the same period last year.

Posted In: EXPO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist